Global Challenges in Paediatric Acute Lymphoblastic Leukaemia

Area of Science:

• Oncology
• Paediatric Haematology
• Global Health

Background:

• Acute lymphoblastic leukaemia (ALL) is a prevalent paediatric cancer and a significant adult malignancy.
• Disparities in ALL outcomes globally correlate with socio-demographic indices (SDIs).

Purpose of the Study:

• To analyze global outcome disparities in acute lymphoblastic leukaemia (ALL).
• To identify challenges and propose solutions for improving ALL treatment across different socio-demographic indices (SDIs).

Main Methods:

• Review of global outcome data for acute lymphoblastic leukaemia (ALL).
• Analysis of treatment strategies and challenges in high, mid, and low socio-demographic index (SDI) regions.

Main Results:

• High-SDI regions achieve >90% cure rates in paediatric ALL, focusing on reducing toxicity with immunotherapies and targeted agents.
• Mid-SDI regions (50-80% cure) need to implement risk-adapted therapy and improve diagnostics and generic drug access.
• Low-SDI regions (<50% cure) face challenges in diagnosis, treatment access, and toxicity management, requiring local adaptation and support.

Conclusions:

• Global partnerships are essential to address shared challenges in ALL.
• Collaborative efforts are needed for affordable therapeutics, biomarker refinement, and evaluating new treatments across diverse populations and SDI regions.